公开(公告)号：US10362784B2

公开(公告)日：2019-07-30

申请号：US15639717

申请日：2017-06-30

Applicant: Timilon Technology Acquisitions LLC

Inventor： Bill Sanford ,  Brandon Walker ,  Paul S. Malchesky ,  Kyle Knappenberger ,  Calvin Jeffrey Kissick ,  Eric Steward

IPC: A01N59/06 ,  A01N59/00 ,  A61Q17/00 ,  A61Q19/10 ,  A61K8/34 ,  A61K8/19 ,  A61K8/27 ,  A61K8/29 ,  A61K8/06 ,  A01N25/22 ,  C09D5/03 ,  C09D1/00 ,  C09D5/14 ,  C09D201/00 ,  C11D1/14 ,  C11D1/72 ,  C11D1/831 ,  C11D3/12 ,  C11D1/66 ,  C11D1/00 ,  C11D3/48 ,  C11D17/00 ,  C09D7/45 ,  C09D7/62 ,  C09D7/65 ,  C09D7/63 ,  C09D7/61 ,  A01N25/10 ,  A01N25/30 ,  C11D1/74 ,  C11D3/00 ,  C11D3/20 ,  C11D3/37 ,  C11D3/382 ,  C11D3/43 ,  C11D17/06 ,  A61K8/39 ,  A61K8/46 ,  A61K8/49 ,  A61K8/81 ,  A61K8/88 ,  A61K8/90 ,  A61K8/02 ,  A61K8/04 ,  C08K3/22

Abstract: Dry mixtures and liquid formulations are provided that comprise metal oxide and/or metal hydroxide nanocrystalline particles. The dry mixtures are advantageously formulated with select surfactants to be readily solubilized and stable in liquid carriers. Additional select components are provided in preferred combinations that are capable of achieving improved biocidal and chemical agent efficacy. Notably, the inventive formulations provided herein allow for easier delivery of the formulations and increased shelf stability.

公开(公告)号：US20180007914A1

公开(公告)日：2018-01-11

申请号：US15639717

申请日：2017-06-30

Applicant: Timilon Technology Acquisitions LLC

Inventor： Bill Sanford ,  Brandon Walker ,  Paul S. Malchesky ,  Kyle Knappenberger ,  Calvin Jeffrey Kissick ,  Eric Steward

IPC: A01N59/06 ,  A01N25/22 ,  C11D3/12 ,  C11D1/831 ,  C11D1/72 ,  C11D1/66 ,  C11D1/14 ,  C11D1/00 ,  C09D201/00 ,  C09D7/12 ,  C09D7/02 ,  C09D5/14 ,  C09D5/03 ,  C09D1/00 ,  A61Q19/10 ,  A61Q17/00 ,  C11D3/48 ,  A61K8/34 ,  A61K8/29 ,  A61K8/27 ,  A61K8/19 ,  A61K8/06 ,  A01N59/00 ,  C11D17/00

CPC classification number: A01N59/06 ,  A01N25/10 ,  A01N25/22 ,  A01N25/30 ,  A01N59/00 ,  A61K8/022 ,  A61K8/04 ,  A61K8/06 ,  A61K8/19 ,  A61K8/27 ,  A61K8/29 ,  A61K8/345 ,  A61K8/39 ,  A61K8/466 ,  A61K8/4993 ,  A61K8/8152 ,  A61K8/88 ,  A61K8/90 ,  A61K2800/413 ,  A61Q17/005 ,  A61Q19/10 ,  C08K3/22 ,  C09D1/00 ,  C09D5/031 ,  C09D5/036 ,  C09D5/14 ,  C09D7/45 ,  C09D7/61 ,  C09D7/62 ,  C09D7/63 ,  C09D7/65 ,  C09D201/00 ,  C11D1/008 ,  C11D1/146 ,  C11D1/667 ,  C11D1/72 ,  C11D1/74 ,  C11D1/831 ,  C11D3/0068 ,  C11D3/1213 ,  C11D3/2065 ,  C11D3/3707 ,  C11D3/3719 ,  C11D3/3761 ,  C11D3/382 ,  C11D3/43 ,  C11D3/48 ,  C11D17/0013 ,  C11D17/06 ,  A01N59/16

Abstract: Dry mixtures and liquid formulations are provided that comprise metal oxide and/or metal hydroxide nanocrystalline particles. The dry mixtures are advantageously formulated with select surfactants to be readily solubilized and stable in liquid carriers. Additional select components are provided in preferred combinations that are capable of achieving improved biocidal and chemical agent efficacy. Notably, the inventive formulations provided herein allow for easier delivery of the formulations and increased shelf stability.